U.S. markets open in 3 hours 3 minutes

OmniAb, Inc. (OABI)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
3.4300-0.1000 (-2.83%)
At close: 04:00PM EDT
3.2600 -0.17 (-4.96%)
After hours: 07:22PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close3.5300
Bid2.7100 x 4000
Ask3.9500 x 900
Day's Range3.2800 - 3.5643
52 Week Range1.9100 - 10.5000
Avg. Volume673,516
Market Cap406.41M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1600
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.33
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for OABI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • OmniAb, Inc.
    Daily – Vickers Top Insider Picks for 02/03/2023The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Fair Value
    Economic Moat
    last monthArgus Research
View more
  • InvestorPlace

    7 Biotech Stocks That Could Be the Next Big Thing

    While the concept of high-risk speculation seems particularly dangerous at this juncture, gamblers may nevertheless want to consider the merits of targeting potentially lucrative biotech stocks that could be the next big thing. These lesser-known enterprises may not command worldwide attention at the moment. Nevertheless, they could yield tremendous profitability if they come through. Another factor that benefits high-risk, high-reward biotech stocks centers on the underlying sector’s permanent

  • Business Wire

    OmniAb to Report Fourth Quarter 2022 Financial Results on March 30

    EMERYVILLE, Calif., March 09, 2023--OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2022 after the close of the U.S. financial markets on Thursday, March 30, 2023 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time.

  • TipRanks

    These 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts

    For investors, the stock market is always a game of risk and reward, and no segment exemplifies that better than the penny stocks. Defined as stocks trading at a price of less than $5, the pennies bring an ultra-low cost of entry to the table, along with a powerful potential for strong gains. At these low initial prices, even a small incremental increase in share price will quickly translate into a high-percentage gain on the initial investment – and for penny stocks’ fans, gains of 200% or even